Related Experiment Videos
Mdm2 promotes the rapid degradation of p53
1Lautenberg Center for General and Tumor Immunology, The Hebrew University Haddassah Medical School, Jerusalem, Israel.
Abstract:
The p53 tumour-suppressor protein exerts antiproliferative effects, including growth arrest and apoptosis, in response to various types of stress. The activity of p53 is abrogated by mutations that occur frequently in tumours, as well as by several viral and cellular proteins. The Mdm2 oncoprotein is a potent inhibitor of p53. Mdm2 binds the transcriptional activation domain of p53 and blocks its ability to regulate target genes and to exert antiproliferative effects. On the other hand, p53 activates the expression of the mdm2 gene in an autoregulatory feedback loop. The interval between p53 activation and consequent Mdm2 accumulation defines a time window during which p53 exerts its effects. We now report that Mdm2 also promotes the rapid degradation of p53 under conditions in which p53 is otherwise stabilized. This effect of Mdm2 requires binding of p53; moreover, a small domain of p53, encompassing the Mdm2-binding site, confers Mdm2-dependent detstabilization upon heterologous proteins. Raised amounts of Mdm2 strongly repress mutant p53 accumulation in tumour-derived cells. During recovery from DNA damage, maximal Mdm2 induction coincides with rapid p53 loss. We propose that the Mdm2-promoted degradation of p53 provides a new mechanism to ensure effective termination of the p53 signal.
Insights
The Mdm2 oncoprotein rapidly degrades the p53 tumor suppressor protein, even when p53 is stabilized. This Mdm2-mediated degradation provides a new mechanism for terminating the p53 signaling pathway.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Signaling
Background:
- The p53 tumor suppressor protein controls cell proliferation, inducing growth arrest and apoptosis in response to stress.
- p53 activity is frequently inhibited by mutations in cancer and by viral/cellular proteins, notably the Mdm2 oncoprotein.
- Mdm2 inhibits p53 by binding its transcriptional activation domain and blocking gene regulation, while p53 autoregulates mdm2 expression.
Purpose of the Study:
- To investigate the role of Mdm2 in regulating p53 protein stability.
- To elucidate the mechanism by which Mdm2 affects p53 levels.
- To understand the implications of Mdm2-mediated p53 degradation in tumor suppression and DNA damage response.
Main Methods:
- Investigated Mdm2's effect on p53 stability under various conditions.
- Utilized binding assays to confirm Mdm2-p53 interaction.
- Employed domain mapping to identify the Mdm2-binding site responsible for p53 destabilization.
- Assessed Mdm2's impact on mutant p53 accumulation in tumor cells and p53 levels during DNA damage recovery.
Main Results:
- Mdm2 actively promotes the rapid degradation of p53, overriding stabilization mechanisms.
- Mdm2 binding to p53 is essential for this degradation.
- A specific p53 domain containing the Mdm2-binding site mediates Mdm2-dependent destabilization.
- Elevated Mdm2 levels significantly reduce mutant p53 accumulation in tumor cells.
- Maximal Mdm2 induction correlates with rapid p53 loss during recovery from DNA damage.
Conclusions:
- Mdm2-mediated degradation of p53 represents a novel mechanism for terminating the p53 signaling pathway.
- This degradation pathway is crucial for regulating p53 activity and its tumor-suppressive functions.
- Understanding this interaction is vital for cancer research and therapeutic strategies targeting the p53-Mdm2 axis.